Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -221,023 | -144,630 | -35,363 | -50,688 | -26,690 |
| Depreciation Amortization | 3,976 | 2,297 | 993 | 7,204 | 5,624 |
| Accounts receivable | -19,133 | -13,517 | -10,380 | -24,240 | -19,523 |
| Other Working Capital | -104,104 | -46,389 | -16,774 | -97,461 | -78,963 |
| Other Operating Activity | 74,044 | 49,317 | 25,856 | -66,811 | -81,386 |
| Operating Cash Flow | $-266,240 | $-152,922 | $-35,668 | $-231,996 | $-200,938 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -88,812 | -46,580 | -1,421 | -293,295 | 195,877 |
| PPE Investments | -40,954 | -20,863 | -12,166 | -12,000 | -8,101 |
| Purchase Of Investment | -353 | -353 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 10,695 | 10,695 |
| Purchase Sale Intangibles | -2,633 | -1,556 | -673 | 115,785 | 116,409 |
| Other Investing Activity | -2,633 | -1,556 | -673 | 115,785 | 116,409 |
| Investing Cash Flow | $-132,752 | $-69,352 | $-14,260 | $-178,815 | $314,880 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 217,722 | 173,354 | 96,235 | 69,708 | 53,620 |
| Debt Repayment | -249,896 | -174,918 | -101,407 | -54,754 | -38,089 |
| Common Stock Issued | 43,031 | 34,386 | 12,643 | 369,183 | 365,738 |
| Other Financing Activity | -1,990 | 0 | 0 | 503,945 | 0 |
| Financing Cash Flow | $8,867 | $32,822 | $7,471 | $888,082 | $381,269 |
| Beginning Cash Position | 599,827 | 599,827 | 599,827 | 122,556 | 122,556 |
| End Cash Position | 209,702 | 410,375 | 557,370 | 599,827 | 617,767 |
| Net Cash Flow | $-390,125 | $-189,452 | $-42,457 | $477,271 | $495,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -266,240 | -152,922 | -35,668 | -231,996 | -200,938 |
| Capital Expenditure | -40,954 | -20,863 | -12,166 | -12,000 | -8,101 |
| Free Cash Flow | -307,194 | -173,785 | -47,834 | -243,996 | -209,039 |